Europe - EBR:ONWD - NL0015000HT4 - Common Stock
The current stock price of ONWD.BR is 4.045 EUR. In the past month the price decreased by -26.72%. In the past year, price decreased by -17.28%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 2M6.DE | MEDTRONIC PLC | 17.33 | 105.58B | ||
| SHL.DE | SIEMENS HEALTHINEERS AG | 23.09 | 49.49B | ||
| PHI1.DE | KONINKLIJKE PHILIPS NV | 17.22 | 23.87B | ||
| PHIA.AS | KONINKLIJKE PHILIPS NV | 17.21 | 23.86B | ||
| BIM.PA | BIOMERIEUX | 27.88 | 12.74B | ||
| AFX.DE | CARL ZEISS MEDITEC AG - BR | 24.96 | 3.82B | ||
| DIA.MI | DIASORIN SPA | 16.98 | 3.30B | ||
| DRW3.DE | DRAEGERWERK AG - PREF | 10.62 | 1.29B | ||
| DRW8.DE | DRAEGERWERK AG | 9.49 | 1.15B | ||
| EUZ.DE | ECKERT & ZIEGLER SE | 27.58 | 1.03B | ||
| ELN.MI | EL.EN. SPA | 17.16 | 880.93M | ||
| GVS.MI | GVS SPA | 48.11 | 819.15M |
Onward Medical NV is a medical technology company, which engages in creating therapies to restore movement, independence, and health in people with spinal cord injury. The company is headquartered in Eindhoven, Noord-Brabant and currently employs 102 full-time employees. The company went IPO on 2021-10-21. The firm is primarily engaged in developing and commercializing innovative therapies to enable functional recovery for people with spinal cord injury. The company develops two technology platforms ARC EX and ARC IM.
ONWARD MEDICAL
Schimmelt 2
Eindhoven NOORD-BRABANT NL
Employees: 102
Onward Medical NV is a medical technology company, which engages in creating therapies to restore movement, independence, and health in people with spinal cord injury. The company is headquartered in Eindhoven, Noord-Brabant and currently employs 102 full-time employees. The company went IPO on 2021-10-21. The firm is primarily engaged in developing and commercializing innovative therapies to enable functional recovery for people with spinal cord injury. The company develops two technology platforms ARC EX and ARC IM.
The current stock price of ONWD.BR is 4.045 EUR. The price decreased by -4.71% in the last trading session.
ONWD.BR does not pay a dividend.
ONWD.BR has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
11 analysts have analysed ONWD.BR and the average price target is 12.63 EUR. This implies a price increase of 212.18% is expected in the next year compared to the current price of 4.045.
ONWARD MEDICAL (ONWD.BR) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.87).
You can find the ownership structure of ONWARD MEDICAL (ONWD.BR) on the Ownership tab.
ChartMill assigns a fundamental rating of 2 / 10 to ONWD.BR. While ONWD.BR seems to be doing ok healthwise, there are quite some concerns on its profitability.
Over the last trailing twelve months ONWD.BR reported a non-GAAP Earnings per Share(EPS) of -0.87. The EPS increased by 20.33% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -68.52% | ||
| ROE | -139.43% | ||
| Debt/Equity | 0.52 |
11 analysts have analysed ONWD.BR and the average price target is 12.63 EUR. This implies a price increase of 212.18% is expected in the next year compared to the current price of 4.045.
For the next year, analysts expect an EPS growth of -16.81% and a revenue growth 426.67% for ONWD.BR